Caroline Chen covers health care for ProPublica. Previously, she worked at Bloomberg News, where she wrote about Valeant Pharmaceutical’s use of a mail order pharmacy to boost reimbursements for its drugs, the tactics used by a rare disease drugmaker to scare patients into staying on therapy, and the plight of medically complex babies who get stranded in hospitals because of a lack of home-care nurses. She received her Master’s degree from the Stabile Program in Investigative Journalism at Columbia University, where she was awarded a Pulitzer Traveling Fellowship.
The CDC fumbled its communication with public health officials and underestimated the threat of the coronavirus even as it gained a foothold in the United States, according to hundreds of pages of documents ProPublica obtained.
The Department of Health and Human Services has come under fire as several states’ requests for supplies from the emergency medical stockpile go unfulfilled. A chaotic distribution plan is buckling under a big problem: Nobody has enough.
Health care reporter Caroline Chen dug into the projections to learn what to make of them. Forecasts are fuzzy, but the takeaway is clear: Stay home.
The FDA’s strict guidance on test confirmations is one of several obstacles that has slowed the federal government’s response to COVID-19. The FDA could change its rules to speed things up, but hasn’t.
Agencies, local authorities and national governments do not agree on who should be quarantined or what that should actually look like. Here’s what we do know.
Are You in Coronavirus Quarantine? Tell Us What Authorities Told You So We Can Make Sure It’s Right.
We’re collecting instructions state and local health departments have given about coronavirus quarantines. Help us hear from every state and city.
I Lived Through SARS and Reported on Ebola. These Are the Questions We Should Be Asking About Coronavirus.
For concerned civilians and journalists covering the coronavirus, the figures and projections can be overwhelming, frightening or confusing. Here’s what reporter Caroline Chen is focusing on to keep things as accurate and clear as possible.
The House Oversight Committee cited ProPublica’s reporting in requesting documents from the Trump administration.
An outbreak would demand peak performance from America’s medical professionals — especially in hospitals. But many of the facilities that may be on the front lines have well-documented histories of failing to prevent the spread of infectious diseases.
Are you a public health worker, medical provider, elected official, patient or other COVID-19 expert? We’re looking for information and sources. Help make sure our journalism is responsible and focused on the right issues.
The CDC designed a flawed test for COVID-19, then took weeks to figure out a fix so state and local labs could use it. New York still doesn’t trust the test’s accuracy.
The New Jersey hospital is taking corrective action after a government investigation spurred by ProPublica’s reporting found that its transplant team was failing to learn from surgical errors.
We’re giving away 20 scholarships to help students attend journalism conferences like NABJ-NAHJ, ONA and IRE. Apply!
Andy Jurtschenko told his children that he didn’t want to be a burden on them. But after he suffered brain damage during a heart transplant at a New Jersey hospital, his medical team deflected their request for a DNR.
The bureau is looking at whether the hospital may have defrauded Medicare and Medicaid as it kept a vegetative patient on life support for the sake of its metrics.
Newark Beth Israel acted after our report that its transplant program kept a patient alive to improve its metrics, while barely consulting his family.
Feds to Investigate Hospital Alleged to Have Kept Vegetative Patient Alive to Game Transplant Survival Rates
Spurred by a ProPublica investigation, the U.S. Centers for Medicare and Medicaid Services will also carry out an inquiry.
“It’s Very Unethical”: Audio Shows Hospital Kept Vegetative Patient on Life Support to Boost Survival Rates
Darryl Young suffered brain damage during a heart transplant at Newark Beth Israel and never woke up. But, hardly consulting his family, doctors kept him alive for a year to avoid federal scrutiny.
This month, we reported R3 Stem Cell was promoting unapproved birth tissue products for a wide range of diseases. This week, the FDA put the company on notice.
How well-meaning donations end up fueling an unproven, virtually unregulated $2 billion stem cell industry.